Nanotechnology for protein delivery: Overview and perspectives.

[1]  F. Szoka,et al.  The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy. , 2015, Advanced drug delivery reviews.

[2]  Zhen Gu,et al.  Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery , 2015, Proceedings of the National Academy of Sciences.

[3]  Karly P Garnock-jones.  Naloxegol: A Review of Its Use in Patients with Opioid-Induced Constipation , 2015, Drugs.

[4]  Zhirong Zhang,et al.  Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. , 2015, ACS nano.

[5]  Zhen Gu,et al.  Furin‐Mediated Sequential Delivery of Anticancer Cytokine and Small‐Molecule Drug Shuttled by Graphene , 2015, Advanced materials.

[6]  Yinsong Wang,et al.  Lactosylated PLGA nanoparticles containing ϵ-polylysine for the sustained release and liver-targeted delivery of the negatively charged proteins. , 2015, International journal of pharmaceutics.

[7]  Chunsheng Xiao,et al.  Synthesis of thermal and oxidation dual responsive polymers for reactive oxygen species (ROS)-triggered drug release , 2015 .

[8]  Benjamin C. Tang,et al.  Managing diabetes with nanomedicine: challenges and opportunities , 2014, Nature Reviews Drug Discovery.

[9]  Zuben E Sauna,et al.  Fc fusion as a platform technology: potential for modulating immunogenicity. , 2015, Trends in biotechnology.

[10]  Roberto A. Maldonado,et al.  Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance , 2014, Proceedings of the National Academy of Sciences.

[11]  Min Jae Lee,et al.  Direct cellular delivery of human proteasomes to delay tau aggregation , 2014, Nature Communications.

[12]  L. de Geus-Oei,et al.  In-treatment assessment of response in locally advanced NSCLC: paving the way for personalized medicine. , 2014, Lung cancer.

[13]  C. Hackenberger,et al.  Site-specific PEGylation of proteins: recent developments. , 2014, The Journal of organic chemistry.

[14]  O. Farokhzad,et al.  A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins , 2014, Nano letters.

[15]  K. Kono,et al.  Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy. , 2014, Biomaterials.

[16]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[17]  Xiaoyang Xu,et al.  Development of multinuclear polymeric nanoparticles as robust protein nanocarriers. , 2014, Angewandte Chemie.

[18]  C. Barbas,et al.  Protein delivery using Cys2-His2 zinc-finger domains. , 2014, ACS chemical biology.

[19]  Dong Ryul Lee,et al.  Cell-penetrating peptide (CPP)-conjugated proteins is an efficient tool for manipulation of human mesenchymal stromal cells , 2014, Scientific Reports.

[20]  Qiaobing Xu,et al.  Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy. , 2014, Angewandte Chemie.

[21]  A. Dömling,et al.  Programmed death-1: therapeutic success after more than 100 years of cancer immunotherapy. , 2014, Angewandte Chemie.

[22]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[23]  Taeghwan Hyeon,et al.  Applications of inorganic nanoparticles as therapeutic agents , 2014, Nanotechnology.

[24]  C. Tung,et al.  Inside Cover: Graphene‐Supported Ultrafine Metal Nanoparticles Encapsulated by Mesoporous Silica: Robust Catalysts for Oxidation and Reduction Reactions (Angew. Chem. Int. Ed. 1/2014) , 2014 .

[25]  R. Ober,et al.  FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions. , 2014, Current topics in microbiology and immunology.

[26]  Ronnie H. Fang,et al.  Nanoparticle-detained toxins for safe and effective vaccination , 2013, Nature nanotechnology.

[27]  B. Rosen,et al.  Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation , 2013, Proceedings of the National Academy of Sciences.

[28]  Y. Kang,et al.  Amphiphilic polysialic acid derivatives: synthesis, characterization, and in-vitro cytotoxicity. , 2013, Journal of nanoscience and nanotechnology.

[29]  R. Langer,et al.  Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery , 2013, Science Translational Medicine.

[30]  R. Jain,et al.  Strategies for advancing cancer nanomedicine. , 2013, Nature materials.

[31]  Huining He,et al.  Long-circulating heparin-functionalized magnetic nanoparticles for potential application as a protein drug delivery platform. , 2013, Molecular pharmaceutics.

[32]  Darrell J Irvine,et al.  Engineering synthetic vaccines using cues from natural immunity. , 2013, Nature materials.

[33]  D. Irvine,et al.  Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination , 2013, Science Translational Medicine.

[34]  V. Rotello,et al.  Direct delivery of functional proteins and enzymes to the cytosol using nanoparticle-stabilized nanocapsules. , 2013, ACS nano.

[35]  Jianlin Shi,et al.  In Vivo Bio‐Safety Evaluations and Diagnostic/Therapeutic Applications of Chemically Designed Mesoporous Silica Nanoparticles , 2013, Advanced materials.

[36]  R. Jain.  Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Daniel G Anderson,et al.  Injectable nano-network for glucose-mediated insulin delivery. , 2013, ACS nano.

[38]  P. Stayton,et al.  pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides. , 2013, ACS nano.

[39]  Dennis E Discher,et al.  Minimal " Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles References and Notes , 2022 .

[40]  Zhen Gu,et al.  Degradable polymeric nanocapsule for efficient intracellular delivery of a high molecular weight tumor-selective protein complex , 2013 .

[41]  Arthur G Erdman,et al.  The big picture on nanomedicine: the state of investigational and approved nanomedicine products. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[42]  D. Betbeder,et al.  Airway delivery of peptides and proteins using nanoparticles. , 2013, Biomaterials.

[43]  W. Haschek,et al.  Haschek and Rousseaux's handbook of toxicologic pathology , 2013 .

[44]  K. Scheffzek,et al.  Enhancing Endosomal Escape of Transduced Proteins by Photochemical Internalisation , 2012, PloS one.

[45]  J. Bluestone,et al.  Current and future immunomodulation strategies to restore tolerance in autoimmune diseases. , 2012, Cold Spring Harbor perspectives in biology.

[46]  Richard A Flavell,et al.  Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. , 2012, Nature materials.

[47]  D. Irvine,et al.  Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. , 2012, ACS nano.

[48]  Zhifeng Shao,et al.  Fc-fusion proteins: new developments and future perspectives , 2012, EMBO molecular medicine.

[49]  Svetlana Gelperina,et al.  Transport of drugs across the blood-brain barrier by nanoparticles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[50]  Kelley W. Moremen,et al.  Vertebrate protein glycosylation: diversity, synthesis and function , 2012, Nature Reviews Molecular Cell Biology.

[51]  R. Locksley,et al.  Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung , 2012, The Journal of experimental medicine.

[52]  M. Goto,et al.  Gold nanorods in an oil-base formulation for transdermal treatment of type 1 diabetes in mice. , 2012, Nanoscale.

[53]  Leaf Huang,et al.  The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles. , 2012, Biomaterials.

[54]  P. Uzor,et al.  Perspectives on Transdermal Drug Delivery , 2011 .

[55]  J. Trowsdale,et al.  Detection of weak receptor–ligand interactions using IgM and J-chain-based fusion proteins , 2012, European journal of immunology.

[56]  Karolina Palucka,et al.  Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.

[57]  Huixia Lv,et al.  Cell Penetrating Peptides in the Delivery of Biopharmaceuticals , 2012, Biomolecules.

[58]  R. Jain,et al.  Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.

[59]  Omid C Farokhzad,et al.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.

[60]  Young Ha Kim,et al.  Efficient skin permeation of soluble proteins via flexible and functional nano-carrier. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[61]  Jinho Park,et al.  Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy , 2012, Theranostics.

[62]  F. Veiga,et al.  Strategies Toward the Improved Oral Delivery of Insulin Nanoparticles via Gastrointestinal Uptake and Translocation , 2012, BioDrugs.

[63]  Yoshio Kato,et al.  targeted gene knockout by direct delivery of zinc-finger nuclease proteins , 2012 .

[64]  F. Nestle,et al.  Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application , 2012, Cancer Immunology, Immunotherapy.

[65]  Jinho Park,et al.  Magnetic nanoparticles and their applications in image-guided drug delivery , 2011, Drug Delivery and Translational Research.

[66]  George Coukos,et al.  Cancer immunotherapy comes of age , 2011, Nature.

[67]  W. van Eden,et al.  PLGA, PLGA-TMC and TMC-TPP Nanoparticles Differentially Modulate the Outcome of Nasal Vaccination by Inducing Tolerance or Enhancing Humoral Immunity , 2011, PloS one.

[68]  Zahi A. Fayad,et al.  Perspectives and opportunities for nanomedicine in the management of atherosclerosis , 2011, Nature Reviews Drug Discovery.

[69]  A. Kurihara,et al.  Distribution of KAI-9803, a Novel δ-Protein Kinase C Inhibitor, after Intravenous Administration to Rats , 2011, Drug Metabolism and Disposition.

[70]  Stephen H. Hughes,et al.  Protein delivery using engineered virus-like particles , 2011, Proceedings of the National Academy of Sciences.

[71]  M. Schilham,et al.  Targeting FcαRI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy , 2011, The Journal of Immunology.

[72]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[73]  Omid C Farokhzad,et al.  Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.

[74]  Zhen Gu,et al.  Tailoring nanocarriers for intracellular protein delivery. , 2011, Chemical Society reviews.

[75]  M. Muda,et al.  Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies. , 2011, Protein engineering, design & selection : PEDS.

[76]  D. Mooney,et al.  Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. , 2011, Nano letters.

[77]  Wah Chiu,et al.  Interbilayer-Crosslinked Multilamellar Vesicles as Synthetic Vaccines for Potent Humoral and Cellular Immune Responses , 2011, Nature materials.

[78]  Kinam Park,et al.  Issues in long-term protein delivery using biodegradable microparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[79]  M. Thanou,et al.  Targeting nanoparticles to cancer. , 2010, Pharmacological research.

[80]  H. Kiyono,et al.  Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. , 2010, Nature materials.

[81]  S. Balu-Iyer,et al.  Delivery of therapeutic proteins. , 2010, Journal of pharmaceutical sciences.

[82]  O. Leavy.  Therapeutic antibodies: past, present and future , 2010, Nature Reviews Immunology.

[83]  Hsin‐Lung Chen,et al.  Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery. , 2010, Biomaterials.

[84]  Vincent M Rotello,et al.  Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. , 2010, Journal of the American Chemical Society.

[85]  Wim E Hennink,et al.  Chitosan-based delivery systems for protein therapeutics and antigens. , 2010, Advanced drug delivery reviews.

[86]  Maurizio Federico,et al.  Lentivirus-based virus-like particles as a new protein delivery tool. , 2010, Methods in molecular biology.

[87]  Zhen Gu,et al.  A novel intracellular protein delivery platform based on single-protein nanocapsules. , 2010, Nature nanotechnology.

[88]  Hak Soo Choi,et al.  Design considerations for tumour-targeted nanoparticles. , 2010, Nature nanotechnology.

[89]  Roberto A. Maldonado,et al.  How tolerogenic dendritic cells induce regulatory T cells. , 2010, Advances in immunology.

[90]  Theodore W Randolph,et al.  Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability. , 2009, Biochemistry.

[91]  Willem P C Stemmer,et al.  A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner , 2009, Nature Biotechnology.

[92]  M. Bawendi,et al.  Design Considerations for Tumor-Targeted Nanoparticles , 2009 .

[93]  Jie-Oh Lee,et al.  Toll-Like Receptor 4 Decoy, TOY, Attenuates Gram-Negative Bacterial Sepsis , 2009, PloS one.

[94]  A. Kabanov,et al.  Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. , 2009, Angewandte Chemie.

[95]  J. Rosenstock,et al.  Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes , 2009, Diabetes Care.

[96]  Elodie Boisselier,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[97]  Robert Langer,et al.  Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. , 2009, Biomaterials.

[98]  J. Kreuter,et al.  Functional Protein Delivery into Neurons Using Polymeric Nanoparticles* , 2009, Journal of Biological Chemistry.

[99]  Robert Blumenthal,et al.  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. , 2009, Critical reviews in therapeutic drug carrier systems.

[100]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[101]  André Pèlegrin,et al.  Cell-penetrating and cell-targeting peptides in drug delivery. , 2008, Biochimica et biophysica acta.

[102]  A. Attama,et al.  Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[103]  Antonios G Mikos,et al.  Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. , 2008, Acta biomaterialia.

[104]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[105]  Rolf Schubert,et al.  In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging , 2008, Circulation.

[106]  E. Chiellini,et al.  Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications. , 2008, Nanomedicine.

[107]  Wen-Tao He,et al.  Transdermal permeation enhancement of N-trimethyl chitosan for testosterone. , 2008, International journal of pharmaceutics.

[108]  S. Bhatia,et al.  Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging , 2008, Advanced materials.

[109]  Martin F. Bachmann,et al.  The coming of age of virus-like particle vaccines , 2008, Biological chemistry.

[110]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[111]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[112]  Christopher J H Porter,et al.  Lipid-based systems for the enhanced delivery of poorly water soluble drugs. , 2008, Advanced drug delivery reviews.

[113]  B. Hutter-Paier,et al.  The Role of Alpha-Synuclein in Neurodegenerative Diseases: A Potential Target for New Treatment Strategies? , 2008, Neurodegenerative Diseases.

[114]  Robert Langer,et al.  Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.

[115]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[116]  Christian Haass,et al.  The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases , 2008, The EMBO journal.

[117]  David E. Golan,et al.  Protein therapeutics: a summary and pharmacological classification , 2008, Nature Reviews Drug Discovery.

[118]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[119]  T. Ramqvist,et al.  Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer , 2007, Expert opinion on biological therapy.

[120]  Wei-Chiang Shen,et al.  Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives , 2007, Pharmaceutical Research.

[121]  Jean-Pierre Benoit,et al.  Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.

[122]  Steven P Schwendeman,et al.  BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. , 2006, Journal of pharmaceutical sciences.

[123]  J. Dobson.  Magnetic nanoparticles for drug delivery , 2006 .

[124]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[125]  A. Bitonti,et al.  Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[126]  Todd Emrick,et al.  Control of protein structure and function through surface recognition by tailored nanoparticle scaffolds. , 2004, Journal of the American Chemical Society.

[127]  J. Kreuter,et al.  Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles , 1999, Pharmaceutical Research.

[128]  V. Sinha,et al.  Biodegradable microspheres for protein delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[129]  M. Lindsay,et al.  Protein transduction domains: are they delivering? , 2003, Trends in pharmacological sciences.

[130]  J. Adamson,et al.  Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein , 2003, Science.

[131]  J. S. Park,et al.  Preparation and evaluation of poly(L-lactic acid) microspheres containing rhEGF for chronic gastric ulcer healing. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[132]  D. Newton,et al.  Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis. , 2000, Cancer research.

[133]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[134]  M Morlock,et al.  Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[135]  N Lotan,et al.  Large porous particles for pulmonary drug delivery. , 1997, Science.

[136]  H. Kleinman,et al.  Neurotoxicity of the human immunodeficiency virus type 1 Tat transactivator to PC12 cells requires the Tat amino acid 49‐58 basic domain , 1995, Journal of neuroscience research.

[137]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[138]  N L Burnham,et al.  Polymers for delivering peptides and proteins. , 1994, American journal of hospital pharmacy.

[139]  R. Cecchelli,et al.  Low‐Density Lipoprotein Receptor on Endothelium of Brain Capillaries , 1989, Journal of neurochemistry.